v3.26.1

BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 11,921	$ 2,590
Prepaid expenses and other current assets	788	773
Total current assets	12,709	3,363
Right-of-use asset, net	96	122
Other assets	1,296	1,298
Total assets	14,101	4,783
Current liabilities:
Accounts payable	583	1,219
Accrued expenses	1,532	508
Lease liability, current portion	31	28
Total current liabilities	2,146	1,755
Lease liability, net of long-term portion	79	110
Total liabilities	2,225	1,865
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock, par value $.0001. Authorized shares of 15,000,000 as of both December 31, 2025 and 2024, respectively. None issued and outstanding as of both December 31, 2025 and 2024.	0	0
Common stock, par value $.0001. Authorized shares of 135,000,000 as of both December 31, 2025 and 2024, respectively. Issued and outstanding shares of 2,524,475 and 604,915 as of December 31, 2025 and 2024, respectively.	0	0
Additional paid-in capital	90,265	69,701
Accumulated deficit	(78,389)	(66,783)
Total stockholders’ equity	11,876	2,918
Total liabilities and stockholders’ equity	$ 14,101	$ 4,783

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

INTENSITY THERAPEUTICS, INC. 10-K